A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)
2019 ◽
Vol 34
(2)
◽
pp. 171-181
◽
Jeff P. Sharman
◽
Anna Marina Liberati
◽
Kenichi Ishizawa
◽
Tahira Khan
◽
Jeffery Robbins
◽
...
Ahmadreza Jamshidi
◽
Farhad Gharibdoost
◽
Mahdi Vojdanian
◽
Soosan G. Soroosh
◽
Mohsen Soroush
◽
...
2020 ◽
Vol 15
(5)
◽
pp. 599-611
Dietger Niederwieser
◽
Caroline Hamm
◽
Patrick Cobb
◽
Mindy Mo
◽
Cecily Forsyth
◽
...
2005 ◽
Vol 58
(5)
◽
pp. 498
◽
Seung Joon Kim
◽
Myung Sook Kim
◽
Sang Haak Lee
◽
Young Kyoon Kim
◽
Hwa Sik Moon
◽
...
2012 ◽
Vol 9
(4)
◽
pp. 1149-1161
◽
Joel M. Kaufman
◽
Michael G. Miller
◽
Sherahe Fitzpatrick
◽
Cecilia McWhirter
◽
John J. Brennan
2018 ◽
Vol 30
(1)
◽
pp. 88-97
◽
Daniel Hänggi
◽
◽
Nima Etminan
◽
Stephan A. Mayer
◽
E. Francois Aldrich
◽
...
1997 ◽
Vol 42
(1)
◽
pp. 249S
◽
J.P. Lépine
◽
R.L. Wiseman
◽
G. Zhu
L. Paz-Ares
◽
K. O'Byrne
◽
T.S.K. Mok
◽
M. Boyer
◽
P.A. Jänne
◽
...
Sunju Park
◽
Jeong-Su Park
◽
Hoyeon Go
◽
Bo-Hyoung Jang
◽
Yongcheol Shin
◽
...
Close
Export Citation Format
Close
Share Document
Close